Price $66.46 |
Market Cap
1.43B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
140.6
|
P/B
9.04
|
P/S
33.33
|
Dividend %
0.30%
|
|
P/CF
83.1
|
P/FCF
160.5
|
Op. Cash Flow
13.6K
|
FCF
0.4
|
|
Op. Margin
26.90%
|
Net Margin
22.70%
|
ROE
9.70%
|
ROI
6.00%
|
|
ROA
8.70%
|
EPS Growth
2.30%
|
Current Ratio
23.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Osmotica Pharmaceuticals PLC (OSMT) | $3.56 | - | - | 247.8M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $60.43 | - | 3.20% | 139.13B | Strong Buy |
| Cara Therapeutics Inc (CARA) | $18.09 | - | - | 959.8M | Strong Buy |
| RCMW Group Inc (HPTYD) | $2.03 | - | - | 14.9M | Strong Buy |
| RadNet Inc. (RDNT) | $18.92 | - | - | 969.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
